HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Impact of iron deficiency on exercise capacity and outcome in heart failure with reduced, mid-range and preserved ejection fraction.

AbstractBACKGROUND:
Little information is available about the prevalence and impact on exercise capacity and outcome of iron deficiency in heart failure with mid-range (HFmrEF) and preserved (HFpEF) ejection fraction in comparison to heart failure with reduced ejection-fraction (HFrEF). Furthermore, no data is available about the progression of ID in patients without baseline anaemia.
METHODS:
We evaluated baseline iron and haemoglobin-status in a single-centre, prospective heart failure database. Baseline functional status, VO2max, echocardiography and clinical-outcome (all-cause mortality and heart failure admissions) were evaluated. ID, anaemia, HFrEF, HFmrEF and HFpEF were defined according to established criteria.
RESULTS:
A total of 1197 patients (71% male) were evaluated (HFrEF, n = 897; HFmrEF, n = 229; HFpEF, n = 72). The overall prevalence of ID was 53% (50% in HFrEF; 61% in HFmrEF; 64% in HFpEF) and 36% for anaemia. ID was associated with a lower VO2max in patients with HFrEF, HFmrEF and HFpEF (p < .001 in all). Iron status more closely related to a poor VO2max than anaemia status (p < .001). Furthermore, poor clinical-outcome was more strongly associated with iron status than anaemia status. Exposing eight patients without anaemia to iron deficiency for 39 months resulted in one patient developing new-onset anaemia (defined as progression of ID). Patients with progression of ID exhibited a significant higher risk of heart failure hospitalisation and all-cause mortality (HR = 1.4; CI = 1.01-1.94; p = .046) than patients without progression.
CONCLUSIONS:
Iron deficiency is common in patients with HFrEF, HFmrEF and HFpEF, and negatively affects VO2max and clinical-outcome. Progression of iron deficiency parallels an increased risk for worsening of heart failure.
AuthorsPieter Martens, Petra Nijst, Frederik H Verbrugge, Kevin Smeets, Matthias Dupont, Wilfried Mullens
JournalActa cardiologica (Acta Cardiol) Vol. 73 Issue 2 Pg. 115-123 (Apr 2018) ISSN: 0001-5385 [Print] England
PMID28730869 (Publication Type: Journal Article, Observational Study)
Chemical References
  • Hemoglobins
  • Iron
Topics
  • Aged
  • Anemia, Iron-Deficiency (epidemiology, etiology, physiopathology)
  • Belgium (epidemiology)
  • Cause of Death (trends)
  • Disease Progression
  • Echocardiography
  • Exercise Tolerance (physiology)
  • Female
  • Follow-Up Studies
  • Heart Failure (complications, mortality, physiopathology)
  • Heart Ventricles (diagnostic imaging, physiopathology)
  • Hemoglobins (metabolism)
  • Humans
  • Iron (blood)
  • Male
  • Prevalence
  • Prognosis
  • Prospective Studies
  • Registries
  • Risk Factors
  • Stroke Volume (physiology)
  • Survival Rate (trends)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: